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Here we report the ﬁrst case described of bacteraemia and
endocarditis by SCV E. faecium in an immunocompetent patient.
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strains possess multiple pathogenicity determinants, while onlyNew Microbes and New Infections © 2015 The Authors. Published by El
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medical isolates [1,2].
Small colony variants (SCV) are slow-growing sub-
populations of bacteria that form phenotypically different, small
colonies on usual culture media compared to conventional
isolates belonging to the same species. This phenotype is often
unstable [3]. The biochemical basis of these phenotypes is
auxotrophism (e.g. menadione, haemin, thymidine), though SCV
where auxotrophism cannot be deﬁned have also been
described [3,4]. Because of their capacity to persist in host cells
and their metabolic and antibiotic resistance features, they are
frequently associated with persistent or recurrent infections
[5]. Staphylococcus aureus SCV have been the most extensively
studied, but SCV have also been described in other staphylo-
cocci and in Gram-negative microorganisms [3]. A very small
number of Enterococcus faecalis SCV have been described
associated with animal or human infections [6,7], and only one
case of Enterococcus faecium SCV [5] has been reported, in an
acute myeloid leukaemia patient who developed sepsis. We
report a case of bacteraemia and endocarditis by SCV E. faecium
in an immunocompetent patient.Case reportA 71-year-old woman with a history of hypertension,
ischaemic heart disease and myocardial infarction was treated
with two percutaneous transluminal coronary angioplasty
stents. She had severe tricuspid and mitral regurgitation,
which was treated with mitral bioprosthesis and tricuspid
annuloplasty.
Six months after heart surgery, she presented to the
emergency department with a blood pressure of 125/54 mm
Hg, heart rate of 100 beats per minute, oxygen saturation of
100% and temperature of 38°C. She complained of midthoracic
discomfort and tenderness in the area of the surgical scar, and
referred to asthenia and anorexia that had existed since her
heart surgery. Heart auscultation detected a systolic multifocal
murmur. Lung auscultation was normal. C-reactive protein was
4.73 mg/dL.
Blood culture grew two morphotypes of Gram-positive,
catalase-negative cocci (Fig. 1). Matrix-assisted laser desorp-
tion/ionization time-of-ﬂight mass spectrometry (MALDI-TOF)
identiﬁed both morphotypes as Enterococcus faecium. A further
blood culture 4 days later yielded the same result.
Both isolates were susceptible to penicillin, ampicillin, van-
comycin and daptomycin, and had a minimum inhibitory con-
centration of gentamicin allowing synergism with β-lactams.
Susceptibility proﬁles were identical for both morphotypes.New Microbe and New Infect 2016; 9: 47–49
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FIG. 1. Normal phenotype and small
colony variants of Enterococcus faecium
isolated from patient with endocarditis.
48 New Microbes and New Infections, Volume 9 Number C, January 2016 NMNITransthoracic echocardiography revealed a decreased ejec-
tion fraction (about 40%) with normal-functioning mitral bio-
prosthesis and competent tricuspid annuloplasty.
Transesophageal echocardiography revealed a broken chordae
tendineae but did not show any other images clearly suggesting
endocarditis.
Computed tomography ruled out other infectious foci. The
patient was admitted to the cardiology ward with a diagnosis of
possible endocarditis according to Duke criteria, with ampicillin
(2 g every 4 hours administered intravenously) and gentamicin
(1 mg/kg every 8 hours administered intravenously) provided
for 6 weeks. Fever decreased soon after initiation of treatment
(temperature decreased to 37.5°C), and blood cultures were
repeatedly negative. The patient became afebrile and was dis-
charged soon after the end of treatment.
For the microorganisms isolated, both the SCV and the
normal phenotype were stable and did not reverse after
several subcultures. While the normal phenotype showed
α-haemolysis, the SCV did not show any haemolysis. The SCV
grew more slowly both in agar plates and broth cultures. The
growth curves of both phenotypes conﬁrmed the slower
growth of the SCV (10- to 15-fold slower during the ﬁrst 6
hours). Multilocus sequence typing sequences were identical
for both morphotypes. Auxotrophism study with nicotin-
amide adenine dinucleotide (NAD), haemin, menadione,
thiamine, timodine and oleic acid did not yield signiﬁcant
colony size differences.
Discussion
SCV have been described in a wide range of species, but SCV
E. faecalis was ﬁrst reported and studied in detail in 2009 [6]New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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geneous in size and shape than normal enterococci. Their cell
walls are thicker than those of normal cells and lack the
bilayer structure, and auxotrophism tests suggest dependence
on different substrates [6]. Growth curves show that SCV
grow more slowly [3]. Just like S. aureus SCV, E. faecalis SCV
have a higher ability to invade and persist in mammalian cells.
E. faecalis SCV have been mainly described in endocarditis
[6,7].
The only case previously described of infection associated
with SCV E. faecium [5] was in a patient with an acute myeloid
leukaemia evolved from a myelodysplastic syndrome; the pa-
tient developed a urinary tract infection and fever during
chemotherapy. E. faecium was cultivated from the urine and
blood cultures with the same susceptibility proﬁle. E. faecium
isolated from blood cultures grew with a normal and a SCV
phenotype. Meropenem plus vancomycin treatment was started
and was further expanded to include liposomal amphotericin B
and acyclovir. The patient became afebrile on day 35 and was
discharged on day 61 after admission.
As in our case, the SCV was stable, showed almost no
haemolysis, and grew more slowly in time–growth curves. Our
isolate did not show any auxotrophism for NAD, haemin,
menadione, thiamine, timodine or oleic acid. SCV enterococci
previously described were auxotrophic for haemin [6]
(E. faecalis), NAD and thymidine (E. faecium) [5]. SCV for
which auxotrophism could not be deﬁned had not been
described for enterococci although they have been described
for other microorganisms [3].
MALDI-TOF correctly identiﬁed the isolate. Previous re-
ports suggest that conventional biochemical tests have someEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 47–49
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of MALDI-TOF in clinical microbiology might increase the
detection and study of SCV enterococci.
As frequently happens with SCV, our isolate was associated
with endocarditis [3,6,7]. Though SCV are frequently resistant to
aminoglycosides, our isolate was susceptible to gentamicin con-
centrations allowing synergism with β-lactams, and β-lactam plus
gentamicin treatment resulted in cure. Though vancomycin
resistance is becoming a serious problem in E. faecium, usually
associated with van genes, both our case and the other SCV
E. faecium case described in humans [5] were vancomycin
susceptible.
A suspicion of SCV when several morphotypes appear in
culture, especially in persistent or recurrent infections, and
their reliable identiﬁcation with MALDI-TOF may allow better
diagnosis and treatment of these patients, as well as better
knowledge about the species in which this behavior can be
expected and the pathogenicity and susceptibility features of
these isolates.Conﬂict of InterestNone declared.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
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